ANI Pharmaceuticals, Inc. (ANIP) Stock

About ANI Pharmaceuticals, Inc.

ANI Pharmaceuticals, Inc. (ANIP) stock trades at $72.61 with a market capitalization of $1.67B. The stock is valued at a price-to-earnings (P/E) ratio of 14.94, price-to-book of 2.56, price-to-sales of 1.68. Over the past 52 weeks the stock has ranged between $69.58 and $97.00, and currently trades 25.1% below its 52-week high.

On profitability, ANI Pharmaceuticals, Inc. generates a return on equity (ROE) of 19.19%, above the typical market range of roughly 12-15%, return on capital employed of 12.41%, an operating margin of 9.17%, a net profit margin of 10.82%.

ANI Pharmaceuticals, Inc. by the numbers, 2016–2025

Between 2016 and 2025 ANI Pharmaceuticals, Inc. reported revenue of $129.0M rising to $883.0M, a change of +584.5% across 10 years. Compounded, revenue has grown 33.5% a year over five years, 40.9% over three, 43.8% over the last twelve months. Net profit rose to $78.0M.

Operating margin went from 15.6% in 2016 to 9.2% in 2025, a fall of 6.4 percentage points. The most recent net margin is 10.82%. On a trailing twelve-month basis to Jun '26, revenue is $978.0M and net profit $105.0M.

Borrowings rose from $121.0M to $325.0M, cash from operations was $185.0M in the latest year, positive in 9 of the last 10.

Return on equity has averaged -2.4% over five years, and was 14.4% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

ANI Pharmaceuticals, Inc. (ANIP) — frequently asked questions